UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Apixaban and dalteparin in active malignancy‐associated venous thromboembolism: The ADAM VTE trial

Journal of thrombosis and haemostasis, 2020-02, Vol.18 (2), p.411-421

2020

Volltextzugriff (PDF)

Prognostic Value of Tumor-Infiltrating Lymphocytes for Patients With Triple-Negative Breast Cancer—Reply

JAMA : the journal of the American Medical Association, 2024-07, Vol.332 (4), p.337

2024

Volltextzugriff (PDF)

A B-wildering Case of Paraplegia: Cobalamin Deficiency

The American journal of medicine, 2013-12, Vol.126 (12), p.1045-1047

2013

Volltextzugriff (PDF)

Characteristics and Spatially Defined Immune (micro)landscapes of Early-stage PD-L1-positive Triple-negative Breast Cancer

Clinical cancer research, 2021-10, Vol.27 (20), p.5628-5637

2021

Volltextzugriff (PDF)

Tumor-Infiltrating Lymphocytes in Patients With Stage I Triple-Negative Breast Cancer Untreated With Chemotherapy

JAMA oncology, 2024-08, Vol.10 (8), p.1077

2024

Volltextzugriff (PDF)

Oxybutynin vs Placebo for Hot Flashes in Women With or Without Breast Cancer: A Randomized, Double-Blind Clinical Trial (ACCRU SC-1603)

JNCI cancer spectrum, 2020-02, Vol.4 (1), p.pkz088-pkz088

2020

Volltextzugriff (PDF)

Association between the use of surveillance PET/CT and the detection of potentially salvageable occult recurrences among patients with resected high-risk melanoma

Melanoma research, 2017-08, Vol.27 (4), p.335-341

2017

Volltextzugriff (PDF)

Nab-paclitaxel in patients with metastatic melanoma

Expert review of anticancer therapy, 2015-12, Vol.15 (12), p.1371-1377

2015

Volltextzugriff (PDF)

Hypereosinophilic syndrome presenting as an unusual triad of eosinophilia, severe thrombocytopenia, and diffuse arterial thromboses, with good response to mepolizumab

Clinical advances in hematology & oncology, 2013-05, Vol.11 (5), p.317-319

2013

Volltextzugriff (PDF)

Current treatment paradigms for triple-negative breast cancer

Minerva Medica, 2024-07

2024

Volltextzugriff (PDF)

Extravasation of oxaliplatin into the mediastinum: a case report and review of the literature

Clinical advances in hematology & oncology, 2012-08, Vol.10 (8), p.546-548

2012

Volltextzugriff (PDF)

Apixaban and dalteparin in active malignancy associated venous thromboembolism: The ADAM VTE Trial

Thrombosis and haemostasis, 2017, Vol.117 (10), p.1952-1961

2017

Volltextzugriff (PDF)

Supporting the Future of the Oncology Workforce: ASCO Medical Student and Trainee Initiatives

Journal of oncology practice, 2018-05, Vol.14 (5), p.277-280

2018

Volltextzugriff (PDF)

Prognostic Value of Tumor-Infiltrating Lymphocytes for Patients With Triple-Negative Breast Cancer

JAMA : the journal of the American Medical Association, 2024-07, Vol.332 (4), p.337

2024

Volltextzugriff (PDF)

Abstract P5-03-07: Distribution of the 21-gene recurrence score (RS) assay (Oncotype DX) in carriers of germline mutations associated with breast cancer predisposition syndromes

Cancer research (Chicago, Ill.), 2020-02, Vol.80 (4_Supplement), p.P5-P5-03-07

2020

Volltextzugriff (PDF)

Abstract P3-08-02: The frequency and somatic mutation landscape of Fibroblast growth factor receptor ( FGFR ) alterations in breast cancer

Cancer research (Chicago, Ill.), 2022-02, Vol.82 (4_Supplement), p.P3-P3-08-02

2022

Volltextzugriff (PDF)

Abstract P4-01-03: Multiomics data reveal novel biomarkers for CDK4/6 resistance

Cancer research (Chicago, Ill.), 2022-02, Vol.82 (4_Supplement), p.P4-P4-01-03

2022

Volltextzugriff (PDF)

Abstract P1-04-01: Digital spatial profiling of immune-related proteins in luminal androgen receptor (LAR) vs non-LAR triple-negative breast cancer (TNBC)

Cancer research (Chicago, Ill.), 2022-02, Vol.82 (4_Supplement), p.P1-P1-04-01

2022

Volltextzugriff (PDF)

Abstract OT2-19-05: A phase I/II trial of abemaciclib and T-DM1 in women and men with HER2-positive advanced or metastatic breast cancer that has progressed on treatment with a taxane, trastuzumab and pertuzumab (THP) (ACCRU-BR-1801)

Cancer research (Chicago, Ill.), 2022-02, Vol.82 (4_Supplement), p.OT2-19-05-OT2-19-05

2022

Volltextzugriff (PDF)

Abstract PD1-08: Frequency, characteristics and prognostic factors of PD-L1+ triple negative breast cancer using the PD-L1 SP142 companion assay

Cancer research (Chicago, Ill.), 2020-02, Vol.80 (4_Supplement), p.PD1-08-PD1-08

2020

Volltextzugriff (PDF)

Abstract P5-04-09: Deep phenotyping using CyTOF identifies peripheral blood immune signatures associated with clinical outcomes and molecular subtypes in patients with early-stage triple negative breast cancer (TNBC)

Cancer research (Chicago, Ill.), 2020-02, Vol.80 (4_Supplement), p.P5-P5-04-09

2020

Volltextzugriff (PDF)

Abstract P1-19-42: Evaluation of mean corpuscular volume (MCV) as a pharmacodynamic predictive biomarker in patients receiving CDK4/6 inhibitors for metastatic breast cancer (MBC)

Cancer research (Chicago, Ill.), 2020-02, Vol.80 (4_Supplement), p.P1-P1-19-42

2020

Volltextzugriff (PDF)

1 – 25 von 75

Suche als RSS-Feed

Aktive Filter

ThemaBreast Cancer

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(71)
Mit Volltextzugriff
(57)

Publikationsform

Artikel
(74)
Buchkapitel
(1)

Sprache

Englisch
(75)

Erscheinungsjahr

n.n

Thema

Life Sciences & Biomedicine
(21)
Science & Technology
(21)
Humans
(15)
Oncology
(14)
Female
(9)
Male
(9)
Middle Aged
(8)
Treatment Outcome
(6)
General & Internal Medicine
(4)
Medicine, General & Internal
(4)
Antineoplastic Combined Chemotherapy Protocols - Adverse Effects
(3)
Care And Treatment
(3)
Chemotherapy
(3)
Medicine
(3)
Melanoma
(3)
Melanoma - Pathology
(3)
Risk Factors
(3)
Skin Neoplasms - Pathology
(3)
Adult
(2)
Anemia
(2)

15 weitere anzeigen...

Weniger anzeigen...

Zeitschrift / Serie

5 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Apixaban and dalteparin in active malignancy‐associated venous thromboembolism: The ADAM VTE trial

Prognostic Value of Tumor-Infiltrating Lymphocytes for Patients With Triple-Negative Breast Cancer—Reply

A B-wildering Case of Paraplegia: Cobalamin Deficiency

Characteristics and Spatially Defined Immune (micro)landscapes of Early-stage PD-L1-positive Triple-negative Breast Cancer

Tumor-Infiltrating Lymphocytes in Patients With Stage I Triple-Negative Breast Cancer Untreated With Chemotherapy

Evaluation of Alisertib Alone or Combined With Fulvestrant in Patients With Endocrine-Resistant Advanced Breast Cancer: The Phase 2 TBCRC041 Randomized Clinical Trial

Oxybutynin vs Placebo for Hot Flashes in Women With or Without Breast Cancer: A Randomized, Double-Blind Clinical Trial (ACCRU SC-1603)

Association between the use of surveillance PET/CT and the detection of potentially salvageable occult recurrences among patients with resected high-risk melanoma

Nab-paclitaxel in patients with metastatic melanoma

Luminal androgen receptor breast cancer subtype and investigation of the microenvironment and neoadjuvant chemotherapy response

Hypereosinophilic syndrome presenting as an unusual triad of eosinophilia, severe thrombocytopenia, and diffuse arterial thromboses, with good response to mepolizumab

Current treatment paradigms for triple-negative breast cancer

Extravasation of oxaliplatin into the mediastinum: a case report and review of the literature

Apixaban and dalteparin in active malignancy associated venous thromboembolism: The ADAM VTE Trial

Supporting the Future of the Oncology Workforce: ASCO Medical Student and Trainee Initiatives

Prognostic Value of Tumor-Infiltrating Lymphocytes for Patients With Triple-Negative Breast Cancer

Abstract P5-03-07: Distribution of the 21-gene recurrence score (RS) assay (Oncotype DX) in carriers of germline mutations associated with breast cancer predisposition syndromes

Abstract P3-08-02: The frequency and somatic mutation landscape of Fibroblast growth factor receptor ( FGFR ) alterations in breast cancer

Abstract P4-01-03: Multiomics data reveal novel biomarkers for CDK4/6 resistance

Abstract P1-04-01: Digital spatial profiling of immune-related proteins in luminal androgen receptor (LAR) vs non-LAR triple-negative breast cancer (TNBC)

Abstract OT2-19-05: A phase I/II trial of abemaciclib and T-DM1 in women and men with HER2-positive advanced or metastatic breast cancer that has progressed on treatment with a taxane, trastuzumab and pertuzumab (THP) (ACCRU-BR-1801)

Abstract P5-13-22: Serum thymidine kinase 1 activity (TKa) levels and progression-free survival (PFS) in patients (pts) with hormone receptor positive (HR+) HER2-negative metastatic breast cancer (MBC) on palbociclib (Pb) and endocrine therapy (ET)

Abstract PD1-08: Frequency, characteristics and prognostic factors of PD-L1+ triple negative breast cancer using the PD-L1 SP142 companion assay

Abstract P5-04-09: Deep phenotyping using CyTOF identifies peripheral blood immune signatures associated with clinical outcomes and molecular subtypes in patients with early-stage triple negative breast cancer (TNBC)

Abstract P1-19-42: Evaluation of mean corpuscular volume (MCV) as a pharmacodynamic predictive biomarker in patients receiving CDK4/6 inhibitors for metastatic breast cancer (MBC)

Aktive Filter

Suchergebnisse filtern